The heart's motion is so powerful that it can recharge devices that save our lives, according to new research from Dartmouth College.

Using a dime-sized invention developed by engineers at the Thayer School of Engineering at Dartmouth, the kinetic energy of the heart can be converted into electricity to power a wide-range of implantable devices, according to the study funded by the National Institutes of Health.

Millions of people rely on pacemakers, defibrillators and other live-saving implantable devices powered by batteries that need to be replaced every five to 10 years. Those replacements require surgery which can be costly and create the possibility of complications and infections.

"We're trying to solve the ultimate problem for any implantable biomedical device," says Dartmouth engineering professor John X.J. Zhang, a lead researcher on the study his team completed alongside clinicians at the University of Texas in San Antonio. "How do you create an effective energy source so the device will do its job during the entire life span of the patient, without the need for surgery to replace the battery?"

"Of equal importance is that the device not interfere with the body's function," adds Dartmouth research associate Lin Dong, first author on the paper. "We knew it had to be biocompatible, lightweight, flexible, and low profile, so it not only fits into the current pacemaker structure but is also scalable for future multi-functionality."

The team's work proposes modifying pacemakers to harness the kinetic energy of the lead wire that's attached to the heart, converting it into electricity to continually charge the batteries.

The added material is a type of thin polymer piezoelectric film called "PVDF" and, when designed with porous structures - either an array of small buckle beams or a flexible cantilever - it can convert even small mechanical motion to electricity. An added benefit: the same modules could potentially be used as sensors to enable data collection for real-time monitoring of patients.

The results of the three-year study, completed by Dartmouth's engineering researchers along with clinicians at UT Health San Antonio, were just published in the cover story for Advanced Materials Technologies.

The two remaining years of NIH funding plus time to finish the pre-clinical process and obtain regulatory approval puts a self-charging pacemaker approximately five years out from commercialization, according to Zhang.

"We've completed the first round of animal studies with great results which will be published soon," says Zhang.

"There is already a lot of expressed interest from the major medical technology companies, and Andrew Closson, one of the study's authors working with Lin Dong and an engineering PhD Innovation Program student at Dartmouth, is learning the business and technology transfer skills to be a cohort in moving forward with the entrepreneurial phase of this effort."

Research paper

Related Links
Dartmouth College
Space Medicine Technology and Systems

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Simply shining light on dinosaur metal compound kills cancer cells
Warwick UK (SPX) Feb 05, 2019
A new compound based on Iridium, a rare metal which landed in the Gulf of Mexico 66 M years ago, hooked onto albumin, a protein in blood, can attack the nucleus of cancerous cells when switched on by light, University of Warwick researchers have found. The treatment of cancer using light, called Photodynamic therapy, is based on chemical compounds called photosensitizers, which can be switched on by light to produce oxidising species, able to kill cancer cells. Clinicians can activate these compou ... read more